Fatigue News and Research

RSS

Clinicians override most electronic medication safety alerts

Computer-based systems that allow clinicians to prescribe drugs electronically are designed to automatically warn of potential medication errors, but a new study reveals clinicians often override the alerts and rely instead on their own judgment.

10 Feb 2009

Drinking lots of soda raises risk for early kidney disease in women

Women who drink two or more cans of soda pop per day are nearly twice as likely to show early signs of kidney disease, a recent study has found.

9 Feb 2009

Scientists identify protein key to Lyme disease

Researchers at UT Southwestern Medical Center have identified a protein that may help give Lyme disease its bite.

9 Feb 2009

Cognitive training can alter the biochemistry of the brain

Researchers at the Swedish medical university Karolinska Institutet have shown for the first time that the active training of the working memory brings about visible changes in the number of dopamine receptors in the human brain.

8 Feb 2009

Research to explore why lupus therapies work for some, not others

The results should shed light not only on the mechanisms behind the disease, but more broadly on the workings of our immune system, especially how our bodies churn out and "train" key combat-ready immune cells, called B-cells.

8 Feb 2009

Even moderate exercise helps breast cancer recovery

Australian researchers have found that exercise can offer benefits to women recovering from breast cancer treatment.

8 Feb 2009

Nothing silent about the way ovarian cancer kills

A new study by Australian scientists has revealed that far from being a silent killer, most women diagnosed with ovarian cancer had one or two unusual and persistent symptoms before they were diagnosed.

3 Feb 2009

Loss of sex drive after menopause affects health, quality of life

Women with low levels of sexual desire, often as a result of menopause, are more likely to be depressed and to suffer physical symptoms such as back pain and memory problems than women who report higher levels of desire, according to a new study by researchers at the University of North Carolina at Chapel Hill and Procter & Gamble Pharmaceuticals.

21 Jan 2009

Blocked Interleukin 21 protein prevents Lupus in mouse model

Mice from a strain that ordinarily develops systemic lupus erythematosus (SLE), but bred with a deficiency in receptor for the protein Interleukin 21, stayed healthy and exhibited none of the symptoms of the disease, researchers at The Jackson Laboratory and National Institutes of Health report.

21 Jan 2009

Anxious seniors may benefit from SSRIs

Many older adults worry - a lot. Almost one in 10 Americans over age 60 suffer from an anxiety disorder that causes them to worry excessively about normal things - like health, finances, disability and family.

21 Jan 2009

Tanning beds provide potential pain relief for fibromyalgia patients

Ultraviolet light may help relieve pain in fibromyalgia syndrome patients, according to a preliminary study at Wake Forest University Baptist Medical Center conducted by dermatology, rheumatology, and public health sciences researchers.

19 Jan 2009

Antidepressants improve symptoms of fibromyalgia

The use of antidepressant medications by patients with fibromyalgia syndrome is associated with a reduction in pain, sleep disturbances and depressed mood and improvement of health-related quality of life, according to an analysis of previous studies, which is published in the January 14, 2009 issue of JAMA.

14 Jan 2009

New Benzothiazepine test will catch sports cheats

Avoiding detection just got harder for drug cheats who try to use a particular range of untested, but potentially enhancing, compounds.

7 Jan 2009

Phase 3 trial begins for Gammagard liquid plus rHuPH20 in primary immunodeficiency patients

Baxter International Inc. and Halozyme Therapeutics, Inc. gas announced the start of a Phase 3 clinical trial of Baxter's Gammagard Liquid [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze Technology) for the treatment of primary immunodeficiency (PID).

From Baxter International Inc. 5 Jan 2009